...
首页> 外文期刊>The American Journal of Tropical Medicine and Hygiene >DECREASED PREVALENCE OF THE PLASMODIUM FALCIPARUM CHLOROQUINE RESISTANCE TRANSPORTER 76T MARKER ASSOCIATED WITH CESSATION OF CHLOROQUINE USE AGAINST P. FALCIPARUM MALARIA IN HAINAN, PEOPLE'S REPUBLIC OF CHINA.
【24h】

DECREASED PREVALENCE OF THE PLASMODIUM FALCIPARUM CHLOROQUINE RESISTANCE TRANSPORTER 76T MARKER ASSOCIATED WITH CESSATION OF CHLOROQUINE USE AGAINST P. FALCIPARUM MALARIA IN HAINAN, PEOPLE'S REPUBLIC OF CHINA.

机译:海南省恶性疟原虫抗疟原虫抗氯转运蛋白转运蛋白76T标记物与停止使用恶性疟原虫的相关性下降。

获取原文
获取原文并翻译 | 示例

摘要

The use of chloroquine treatment for Plasmodium falciparum malaria was abandoned in China in 1979 because of widespread drug resistance. Subsequent studies found decreases in the prevalence of chloroquine-resistant strains. To evaluate these decreases and assess the current status of chloroquine sensitivity in Hainan, China, we determined the prevalence of the P. falciparum chloroquine resistance transporter (PfCRT) 76T marker in the DNA of blood samples collected from 1978 to 2001. Results showed the presence of PfCRT 76T in 101 of 112 samples (90%) from 1978 to 1981, 30 of 43 samples (70%) from 1986, 22 of 34 samples (65%) from 1997 to 1998, and 37 of 68 samples (54%) from 2001. The prevalence of PfCRT 76T thus progressively decreased after chloroquine was discontinued as a treatment for P. falciparum malaria (chi(2) = 5.2, P < 0.022 [1978-1981 versus 1986]; chi(2) = 7.4, P < 0.006 [1978-1981 versus 1997-1998]; and chi(2) = 28.8, P < 0.0001 [1978-1981 versus 2001]). Reduced prevalence of the PfCRT 76T marker is consistent with greater rates of chloroquine sensitivity from in vitro drug assays of blood samples in 1997 and 2001. Monitoring for continued decreases will provide valuable information for future drug-use policies in China.
机译:由于广泛的耐药性,1979年在中国放弃使用氯喹治疗恶性疟原虫疟疾。随后的研究发现耐氯喹菌株的流行率降低。为了评估这些下降并评估中国海南省对氯喹的敏感性,我们确定了从1978年至2001年采集的血液DNA中恶性疟原虫氯喹抗性转运蛋白(PfCRT)76T标记的普遍性。 1978年至1981年的112个样本中的101个(90%)中的PfCRT 76T,1986年以来的43个样本中的30个(70%),1997年至1998年的34个样本中的22个(65%)和68个样本中的37个(54%)从2001年开始。PfCRT76T的发生率因此在停止使用氯喹治疗恶性疟原虫之后逐渐降低(chi(2)= 5.2,P <0.022 [1978-1981 vs 1986]; chi(2)= 7.4,P <0.006 [1978-1981与1997-1998]; chi(2)= 28.8,P <0.0001 [1978-1981与2001])。 PfCRT 76T标记物降低的患病率与1997年和2001年通过对血液样本进行体外药物测定得出的氯喹敏感性更高。同时,对持续下降的监测将为中国未来的药物使用政策提供有价值的信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号